Predictmedix
See what makes us different.
We develop disruptive AI technologies for
health and safety in workplaces and healthcare.
At our core, we are an artificial intelligence company developing disruptive tools for impairment testing and healthcare. We are developing AI based screening for the healthcare and workplace industries.
The recent advent of the COVID-19 pandemic has placed unprecedented stress on the global economy and highlights the need for tools to help screen mass populations for infectious diseases, with the hope of preventing pandemics in the future. In turn, we have expanded our proprietary AI technology to screen for infectious diseases such as COVID-19.
In addition to our Infectious Disease, Impairment, and Mental Disorders Screening tools, we have also acquired a TeleHealth Remote Patient Monitoring Platform that has been successful at many hospitals and trials.
Our Strategic Partnerships
TECH MAHINDRA
Top 15 global IT companies as ranked by Forbes. $4.9B company owned by Mahindra Group (part of a $420.7B federation of companies).
McGILL UNIVERSITY
One of Canada’s best-known institutions of higher learning and a leading university in the world.
MAX HEALTHCARE
One of India’s leading providers of comprehensive healthcare services with a network of 14 hospitals and 2,300+ leading
doctors.
MGM HOSPITAL
The Mahatma Gandhi Mission (MGM) New Bombay Hospital Vashi is one of the most advanced multi-specialty tertiary care centers in the heart of Navi Mubai in India.
JUICEWORKS EXHIBITS
Full-service expert in fabrication and management of exhibitions, events and experiences for leading brands with operations across North America.
INDIAN INSTITUTE OF TECHNOLOGY (IIT)
Top ranked engineering school globally. Alumni: CEOs & CTOs working at many Fortune 500 companies including Google, IBM, and Microsoft.
PARAS DEFENSE
India’s most progressive Tier 2 defence engineering company targeting the government and the public sector markets in
South Asia.
Our Products + Services
Our Rapid Mass Screening technology uses multispectral cameras and sensors to capture data patterns that are instantly analyzed by our AI models.
Our Remote Care Platform integrates wearables and Bluetooth devices that bring data together with compassionate care tools for specific applications.
INFECTIOUS DISEASES SCREENING SOLUTIONS
Our screening solutions are powered by AI. We use multispectral cameras and sensors that capture data patterns that are instantly analyzed by our proprietary AI. Our AI models continuously evolve via Machine Learning to keep you safe. That is the power of AI.
CANNABIS & ALCOHOL IMPAIRMENT SCREENING
Our Cannabis & Alcohol Screening technology tests for impairment using multispectral recognition technologies that capture data analyzed by our proprietary AI.
MENTAL ILLNESS DIAGNOSTICS
Mental illness is difficult to detect at early stages. Primarily due to a lack of diagnostic tools other than standardized surveys and subjective assessment from trained healthcare practitioners.
Using multispectral image patterns, we will be able to effectively determine signs of mental illnesses, including depression, dementia, and Alzheimer’s.
REMOTE PATIENT CARE
Our Remote Patient Monitoring & Telehealth platform for Long Term Care and Retirement Residences, Clinical Research Organizations, and Large Scale Employers.
Meet The Team
Prabhakar Srivastava
Dr. Deepu Banjeri
Dr. Dawn Decunha
Rakesh Malhotra
Dr. Navdeep Singh Nanda
Dr. Indranil Saha
Dr. Nitin Kadam
Kiran Kkumari
Dr. Tally Bodenstein
“My team and I are looking forward to working with Predictmedix team. Predictmedix is one of the young and leading AI companies which aims to improve our healthcare system through innovative and cutting-edge digital health technologies.”
“The most interesting part is that Predictmedix focuses on AI solutions to problems that matter to all of us”
In the News
Predictmedix Inc. Files Registration Statement on Form 20-F with the SEC
Toronto, ON / June 18, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), announced today that it has filed a registration statement on Form 20-F to register its common shares with the United States Securities and Exchange...
Predictmedix Announces Partnership with SBL Testing Technologies for Distribution of Safe Entry Stations
Toronto, ON / June 11, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), is pleased to announce expansion of their Safe Entry program with the institution of their first distributor, SBL Testing Technologies Inc (SBL) in partnership...
Predictmedix Deploys Safe Entry Stations at the Italian Contemporary Film Festival
Toronto, ON / June 3, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), is pleased to announce the deployment of Safe Entry Stations at the Lavazza Drive In Film Festival to be held in Ontario from June 27 to July 17. ...